Tibet Weixinkang Medicine Co., Ltd. (603676.SS)

CNY 10.26

(-1.25%)

Revenue Summary of Tibet Weixinkang Medicine Co., Ltd.

  • Tibet Weixinkang Medicine Co., Ltd.'s latest annual revenue in 2023 was 1.32 Billion CNY , down -5.43% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 361.12 Million CNY , up 15.69% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported a annual revenue of 1.39 Billion CNY in annual revenue 2022, up 35.31% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported a annual revenue of 1.03 Billion CNY in annual revenue 2021, up 44.43% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported a quarterly revenue of 312.14 Million CNY for 2024 Q2, down -1.79% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported a quarterly revenue of 361.12 Million CNY for 2024 Q3, up 15.69% from previous quarter.

Annual Revenue Chart of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Historical Annual Revenue of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Year Revenue Revenue Growth
2023 1.32 Billion CNY -5.43%
2022 1.39 Billion CNY 35.31%
2021 1.03 Billion CNY 44.43%
2020 715.66 Million CNY -3.41%
2019 740.96 Million CNY -0.72%
2018 746.32 Million CNY 77.54%
2017 420.38 Million CNY -1.4%
2016 426.36 Million CNY -3.15%
2015 440.23 Million CNY 12.65%
2014 390.79 Million CNY 14.17%
2013 342.29 Million CNY 0.0%

Peer Revenue Comparison of Tibet Weixinkang Medicine Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 86.3%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 54.544%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 78.482%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 83.894%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 91.43%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 84.522%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 83.914%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -571.971%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 92.054%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -105.071%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 29.359%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 75.535%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 72.829%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 76.054%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -81.831%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 91.377%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 83.03%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 87.27%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 94.564%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -133.93%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 64.581%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 82.662%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 60.059%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -53.63%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY -8.726%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY -14.432%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 52.387%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -128.02%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 98.249%
China National Medicines Corporation Ltd. 49.69 Billion CNY 97.339%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -156.434%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -56.463%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 68.389%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 92.595%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 86.931%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 87.061%
CanSino Biologics Inc. 345.18 Million CNY -283.174%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 87.249%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 57.853%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -206.888%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -1415.583%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 26.992%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -353.087%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 69.436%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 57.834%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 70.36%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -96.932%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 7.687%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 96.805%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 18.783%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 57.286%
Guobang Pharma Ltd. 5.34 Billion CNY 75.275%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -96.542%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 90.014%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 39.259%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 72.863%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 36.101%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 65.18%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 66.357%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY -41.897%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 88.915%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -267.144%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 57.281%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY -43.712%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 39.163%